Trailing-twelve-month (TTM) revenue is $1.13 Billion with a year-over-year growth of (15.92%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-11-01 | $339,466,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-16 |
| Q4 FY2025Period ended 2026-01-31 | $329,233,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-10 |
| Q1 FY2026Period ended 2026-05-02 | $215,225,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-12 |
| Q2 FY2026Period ended 2026-08-01 | $241,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-14 |
| TTM revenue | $1,125,724,000 |
Current P/S: $42,472,798 market capitalization ÷ $1,125,724,000 TTM revenue = 0.04x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-08-01.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-08-01): $241.80M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:17:57.071Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-30 · USD | FY20212022-01-29 · USD | FY20222023-01-28 · USD | FY20232024-02-03 · USD | FY20242025-02-01 · USD | FY20252026-01-31 · USD |
|---|---|---|---|---|---|---|
| The Children's Place Canada | $151M | N/A | N/A | N/A | N/A | $105M |
| The Children's Place International | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212022-01-29 · USD | FY20222023-01-28 · USD | FY20232024-02-03 · USD | FY20242025-02-01 · USD | FY20252026-01-31 · USD |
|---|---|---|---|---|---|
| Midwest | $242M | $196M | $185M | $147M | $129M |
| Northeast | $413M | $339M | $305M | $255M | $236M |
| South |
$1.13B
$1.13 Billion
(15.92%)
vs. $1.34B a year ago (TTM)
(8.42%)
5 Year compound annual growth rate
1 Year
(15.92%)
3 Year
(11.62%)
5 Year
(8.42%)
10 Year
(4.29%)
15 Year
(2.64%)
20 Year
(2.33%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.21B | ($177.44M) | (12.80%) |
| 2024 | $1.39B | ($216.24M) | (13.49%) |
| 2023 | $1.60B | ($105.97M) | (6.20%) |
| 2022 | $1.71B | ($206.88M) | (10.80%) |
| 2021 | $1.92B | +$392.77M | +25.80% |
| 2020 |
TTM Growth
(15.92%)
3-Year CAGR
(11.62%)
5-Year CAGR
(8.42%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:17:57.071Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $175M |
| $145M |
| $120M |
| N/A |
| The Childrens Place US Member | N/A | $1.7B | $1.5B | $1.5B | $1.3B | $1.1B |
|---|
| $633M |
| $586M |
| $502M |
| $444M |
| West | $277M | $231M | $208M | $166M | $152M |
|---|
| $1.52B |
| ($348.07M) |
| (18.61%) |
| 2019 | $1.87B | ($67.42M) | (3.48%) |
| 2018 | $1.94B | +$67.81M | +3.63% |
| 2017 | $1.87B | +$84.96M | +4.76% |
| 2016 | $1.79B | +$59.54M | +3.45% |
